Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10478-1 | A-1210477 |  | |||
| 10390-1 | Abemaciclib | LY2835219 |  | 46220502 | |
| 10179-1 | ABT-737 | LSM-1180 |  | 11228183 | |
| 10233-1 | Alpelisib | BYL719 | LSM-4256 |  | 56649450 |
| 10006-1 | AZD7762 | LSM-1006 |  | 67077825 | |
| 10482-1 | Bleomycin | Blenoxane |  | 456190 | |
| 10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 |  | 16654980 |
| 10194-1 | Cabozantinib | XL-184; BMS-907351 | LSM-1195 |  | 25102847 |
| 10444-1 | Cediranib | Recentin; AZD2171 |  | 9933475 | |
| 10394-1 | Ceritinib | LDK378 |  | 57379345 | |
| 10245-4 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 |  | |
| 10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 |  | 3062316 |
| 10287-2 | Dinaciclib | SCH727965 | LSM-6306 |  | 46926350 |
| 10248-3 | Doxorubicin | Adriamycin | LSM-4062 |  | 31703 |
| 10250-3 | Etoposide | LSM-6348 |  | 36462 | |
| 10235-1 | Everolimus | RAD001 | LSM-4258 |  | 53398658 |
| 10205-1 | INK-128 | MLN0128 | LSM-1206 |  | 45375953 |
| 10338-1 | Ipatasertib | GDC 0068; GDC-0068; GDC0068; RG 7440; RG-7440; RG7440 | LSM-6341 |  | 24788740 |
| 10161-1 | Luminespib | NVP-AUY922 | LSM-1162 |  | 53401173 |
| 10018-1 | Neratinib | HKI-272 | LSM-42778 |  | 53398697 |
| 10144-3 | Olaparib | AZD2281; KU-0059436 | LSM-1145 |  | 23725625 |
| 10071-1 | Palbociclib | PD0332991 | LSM-1071 |  | 5330286 |
| 10404-1 | PF-4708671 |  | 51371303 | ||
| 10047-1 | Pictilisib | Pictrelisib; GDC-0941; RG-7321 | LSM-1047 |  | 17755052 |
| 10032-1 | Saracatinib | AZD0530 | LSM-1032 |  | 10302451 |